Rivean Capital-backed To-Increase completed the acquisition of AX for Pharma.

Rivean Capital-backed To-Increase, a business software solutions provider, completed the acquisition of AX for Pharma, an integrated ERP solution provider for the pharmaceutical industry. Financial terms were not disclosed. "Today’s announcement is a testament to our teams’ exceptional work in empowering and digitalizing pharmaceutical, biotech, and medical device companies worldwide. We will leverage To Increase’s platform to reach and support our existing and new customers globally with our combined industry-leading solutions for life sciences. A special thanks to Luciano and the leadership team at To-Increase who made this possible,” Andrea Ruosi, AX for Pharma CEO.